Aldosterone blockade in cardiovascular disease.
Struthers
Allan D
AD
Division of Medicine & Therapeutics, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK. a.d.struthers@dundee.ac.uk
D000450:Aldosterone / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002309:Cardiology / Q000193:education*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004502:Education, Medical, Continuing; D004730:Endothelium, Vascular / Q000378:metabolism; D005355:Fibrosis; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007668:Kidney / Q000378:metabolism; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D000450:Aldosterone